Precision therapeutics and emerging strategies for HR-positive metastatic breast cancer
Maxwell R. Lloyd(Beth Israel Deaconess Medical Center), Seth A. Wander(Harvard University), Kevin Kalinsky(Emory University), Aditya Bardia(UCLA Health), Komal Jhaveri(Memorial Sloan Kettering Cancer Center)
Cited by 55
Related Papers
Circulating Tumor Cell Clusters Are Oligoclonal Precursors of Breast Cancer Metastasis
|Cell|2014|2.5k
Circulating Breast Tumor Cells Exhibit Dynamic Changes in Epithelial and Mesenchymal Composition
|Science|2013|2.5k
Inertial Focusing for Tumor Antigen–Dependent and –Independent Sorting of Rare Circulating Tumor Cells
|Science Translational Medicine|2013|1.1k
Overall Survival with Ribociclib plus Endocrine Therapy in Breast Cancer
|New England Journal of Medicine|2019|1k